Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study.

Fully informed consent can be needlessly cruel.

levels in the metabolic derangement of diabetes. N Engl J. Med 1984;310: 810-5. 19 Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM. Serum IGF-1 concentration in diabetic retinopathy. Diabetic Med 1988;5:356-60. 20 Sharp PS, Fallon TJ, Brazier OJ, Sandler L, Joplin GF, Kohner EM. Long term follow up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative ret...

Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. Interim report of multicentre randomised controlled trial.

One hundred patients with symmetrical proliferative diabetic retinopathy had one eye randomly chosen for treatment with xenonarc photocoagulation while the other was left untreated as a control. Patients were subdivided into those with new vessels on both optic discs and those with only peripheral new vessels. In patients with new vessels on the optic discs the vision of the untreated eyes dete...

Xenon arc photocoagulation in the treatment of diabetic maculopathy.

A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.

We present the results of a randomised study comparing xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Our results show that when used in the way described below there is no significant difference between the effect of the 2 treatments on optic disc neovascularisation and visual acuity. We also compare the results of peripheral retinal ablation...

The 5-year prognosis for vision in diabetes.

DIABETIC retinopathy is a common cause of blindness. The introduction of photocoagulation treatment has stimulated interest in this condition and several well designed and properly controlled studies have shown that either xenon arc or argon laser photocoagulation therapy can arrest or delay the progression of diabetic retinopathy.1-7 This treatment is now available at many centres in the UK, a...